Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy. (Q46870915)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Irbesartan/HCTZ fixed combinations in patients of different racial/ethnic groups with uncontrolled systolic blood pressure on monotherapy (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Elizabeth O Ofili

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Keith C Ferdinand

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Elijah Saunders

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Joel M Neutel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

George L Bakris

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

William C Cushman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

James R Sowers

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Michael A Weber

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

1 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

Journal of the National Medical Association

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

98

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

618-626

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16623075%20AND%20SRC:MED&resulttype=core&format=json

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure

19 January 2020

cites work

1 reference

12 December 2020

Valsartan alone or with a diuretic or ACE inhibitor as treatment for African American hypertensives: relation to salt intake

1 reference

12 December 2020

Irbesartan reduces the albumin excretion rate in microalbuminuric type 2 diabetic patients independently of hypertension: a randomized double-blind placebo-controlled crossover study.

1 reference

12 December 2020

The efficacy and safety of low- and high-dose fixed combinations of irbesartan/hydrochlorothiazide in patients with uncontrolled systolic blood pressure on monotherapy: the INCLUSIVE trial

1 reference

12 December 2020

Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension

1 reference

12 December 2020

Black Americans have an increased rate of angiotensin converting enzyme inhibitor-associated angioedema

1 reference

12 December 2020

Hypertension in blacks

1 reference

12 December 2020

Regional and racial differences in response to antihypertensive medication use in a randomized controlled trial of men with hypertension in the United States. Department of Veterans Affairs Cooperative Study Group on Antihypertensive Agents

1 reference

12 December 2020

Once-daily fixed-combination irbesartan 300 mg/ hydrochlorothiazide 25 mg and circadian blood pressure profile in patients with essential hypertension

1 reference

12 December 2020

Higher incidence of discontinuation of angiotensin converting enzyme inhibitors due to cough in black subjects

1 reference

12 December 2020

Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)

1 reference

12 December 2020

The prevalence of prehypertension and hypertension among US adults according to the new joint national committee guidelines: new challenges of the old problem

1 reference

12 December 2020

Evaluation of candesartan cilexetil in black patients with systemic hypertension: the ABC Trial.

1 reference

12 December 2020

ACE inhibitors and target organ protection. An expanded role for these antihypertensive agents?

1 reference

12 December 2020

Management of high blood pressure in African Americans: consensus statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks

1 reference

12 December 2020

Antihypertensive efficacy and safety of losartan alone and in combination with hydrochlorothiazide in adult African Americans with mild to moderate hypertension

1 reference

12 December 2020

The impact of ethnicity on response to antihypertensive therapy

1 reference

12 December 2020

The effects of irbesartan added to hydrochlorothiazide for the treatment of hypertension in patients non-responsive to hydrochlorothiazide alone

1 reference

12 December 2020

The antihypertensive efficacy of the combination of irbesartan and hydrochlorothiazide assessed by 24-hour ambulatory blood pressure monitoring. Irbesartan Multicenter Study Group

1 reference

12 December 2020

Effect of race on hypertension and antihypertensive therapy

1 reference

12 December 2020

The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes

1 reference

12 December 2020

The burden of adult hypertension in the United States 1999 to 2000: a rising tide.

1 reference

12 December 2020

Factors associated with hypertension control in the general population of the United States

1 reference

12 December 2020

Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes

1 reference

12 December 2020

Matrix study of irbesartan with hydrochlorothiazide in mild-to-moderate hypertension

1 reference

12 December 2020

ARBs and target organ protection. Exploring benefits beyond their antihypertensive effects

1 reference

12 December 2020

Evaluation of three devices for self-measurement of blood pressure according to the revised British Hypertension Society Protocol: the Omron HEM-705CP, Philips HP5332, and Nissei DS-175

1 reference

12 December 2020

Identifiers

1 reference